Pacific Biomarkers Inc., a leading provider of specialized biomarker and contract research services, today announced its operating results for the second quarter and first half of fiscal year 2011, noting industry challenges and the company???s strategy for overcoming them. ???Our results for the three months ended December 31, 2010, are a reflection of the challenging drug development environment